High-Throughput Screening for Bioactive Molecules Using Primary Cell Culture of Transgenic Zebrafish Embryos

Cell Reports

Volumn 2, Issue 3, 2012, Pages 695-704

  Huang, Haigen ^a   Lindgren, Anne ^a   Wu, Xinrong ^b   Liu, Ning Ai ^a   Lin, Shuo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Liuhuaqiao Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOMATION; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYO CELL; EMBRYONIC STEM CELL; FLK1 GENE; GENE; HEART MUSCLE CELL; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMAGING SYSTEM; NONHUMAN; PANCREAS CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE SPECIFICITY; TRANSGENIC ANIMAL; UMBILICAL VEIN ENDOTHELIAL CELL; ZEBRA FISH;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; EMBRYO, MAMMALIAN; EMBRYO, NONMAMMALIAN; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; ORGAN SPECIFICITY; ZEBRAFISH;

ANIMALIA; DANIO RERIO; MAMMALIA; MURINAE;

EID: 84866912427     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.08.015     Document Type: Article

References (39)

1. Cao Z., Jensen L.D., Rouhi P., Hosaka K., Länne T., Steffensen J.F., Wahlberg E., Cao Y. Hypoxia-induced retinopathy model in adult zebrafish. Nat. Protoc. 2010, 5:1903-1910.
2. Chen Z., Liu F., Ren Q., Zhao Q., Ren H., Lu S., Zhang L., Han Z. Hemangiopoietin promotes endothelial cell proliferation through PI-3K/Akt pathway. Cell. Physiol. Biochem. 2008, 22:307-314.
3. Cross M.J., Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 2001, 22:201-207.
4. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
5. Djonov V., Schmid M., Tschanz S.A., Burri P.H. Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ. Res. 2000, 86:286-292.
6. Figueroa X.F., Poblete M.I., Boric M.P., Mendizábal V.E., Adler-Graschinsky E., Huidobro-Toro J.P. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br. J. Pharmacol. 2001, 134:957-968.
7. Figueroa X.F., Poblete I., Fernández R., Pedemonte C., Cortés V., Huidobro-Toro J.P. NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H134-H143.
8. Finger S., Dunnett S.B. Nimodipine enhances growth and vascularization of neural grafts. Exp. Neurol. 1989, 104:1-9.
9. Fong T.A., Shawver L.K., Sun L., Tang C., App H., Powell T.J., Kim Y.H., Schreck R., Wang X., Risau W., et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 1999, 59:99-106.
10. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002, 21:1743-1753.
11. Holmes K., Chapman E., See V., Cross M.J. VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta. PLoS ONE 2010, 5:e11435.
12. Hood J., Granger H.J. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J. Biol. Chem. 1998, 273:23504-23508.
13. Huang H., Vogel S.S., Liu N., Melton D.A., Lin S. Analysis of pancreatic development in living transgenic zebrafish embryos. Mol. Cell. Endocrinol. 2001, 177:117-124.
14. James D., Levine A.J., Besser D., Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005, 132:1273-1282.
15. Lally B.E., Geiger G.A., Kridel S., Arcury-Quandt A.E., Robbins M.E., Kock N.D., Wheeler K., Peddi P., Georgakilas A., Kao G.D., Koumenis C. Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Res. 2007, 67:8791-8799.
16. Liu Z., Kobayashi K., van Dinther M., van Heiningen S.H., Valdimarsdottir G., van Laar T., Scharpfenecker M., Löwik C.W., Goumans M.J., Ten Dijke P., Pardali E. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. J. Cell Sci. 2009, 122:3294-3302.
17. Long Q., Meng A., Wang H., Jessen J.R., Farrell M.J., Lin S. GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development 1997, 124:4105-4111.
18. Makanya A.N., Hlushchuk R., Djonov V.G. Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling. Angiogenesis 2009, 12:113-123.
19. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
20. Murphey R.D., Stern H.M., Straub C.T., Zon L.I. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem. Biol. Drug Des. 2006, 68:213-219.
21. Nakatsu M.N., Sainson R.C., Pérez-del-Pulgar S., Aoto J.N., Aitkenhead M., Taylor K.L., Carpenter P.M., Hughes C.C. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab. Invest. 2003, 83:1873-1885.
22. Parsons-Wingerter P., Elliott K.E., Clark J.I., Farr A.G. Fibroblast growth factor-2 selectively stimulates angiogenesis of small vessels in arterial tree. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1250-1256.
23. Pattillo C.B., Bir S.C., Branch B.G., Greber E., Shen X., Pardue S., Patel R.P., Kevil C.G. Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. Free Radic. Biol. Med. 2011, 50:262-269.
24. Patton E.E., Zon L.I. The art and design of genetic screens: zebrafish. Nat. Rev. Genet. 2001, 2:956-966.
25. Peterson R.T., Link B.A., Dowling J.E., Schreiber S.L. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA 2000, 97:12965-12969.
26. Peterson R.T., Shaw S.Y., Peterson T.A., Milan D.J., Zhong T.P., Schreiber S.L., MacRae C.A., Fishman M.C. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol. 2004, 22:595-599.
27. Poole T.J., Finkelstein E.B., Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev. Dyn. 2001, 220:1-17.
28. Saad M.A., Elghozi J.L., Meyer P. Baroreflex sensitivity alteration following transient hemispheric ischaemia in rats: protective effect of alphamethyldopa and guanfacine. Clin. Exp. Pharmacol. Physiol. 1986, 13:525-534.
29. Seghezzi G., Patel S., Ren C.J., Gualandris A., Pintucci G., Robbins E.S., Shapiro R.L., Galloway A.C., Rifkin D.B., Mignatti P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 1998, 141:1659-1673.
30. Serbedzija G.N., Flynn E., Willett C.E. Zebrafish angiogenesis: a new model for drug screening. Angiogenesis 1999, 3:353-359.
31. Stern H.M., Zon L.I. Cancer genetics and drug discovery in the zebrafish. Nat. Rev. Cancer 2003, 3:533-539.
32. Torry R.J., O'Brien D.M., Connell P.M., Tomanek R.J. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am. J. Physiol. 1992, 262:H980-H986.
33. Twentyman P.R., Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br. J. Cancer 1987, 56:279-285.
34. Venkatesh P.K., Pattillo C.B., Branch B., Hood J., Thoma S., Illum S., Pardue S., Teng X., Patel R.P., Kevil C.G. Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc. Res. 2010, 85:661-670.
35. Watabe T., Nishihara A., Mishima K., Yamashita J., Shimizu K., Miyazawa K., Nishikawa S., Miyazono K. TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J. Cell Biol. 2003, 163:1303-1311.
36. Wen L., Wei W., Gu W., Huang P., Ren X., Zhang Z., Zhu Z., Lin S., Zhang B. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 2008, 314:84-92.
37. Yu P.B., Hong C.C., Sachidanandan C., Babitt J.L., Deng D.Y., Hoyng S.A., Lin H.Y., Bloch K.D., Peterson R.T. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 2008, 4:33-41.
38. Zhang X.Y., Rodaway A.R. SCL-GFP transgenic zebrafish: in vivo imaging of blood and endothelial development and identification of the initial site of definitive hematopoiesis. Dev. Biol. 2007, 307:179-194.
39. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.